NCT04270045 Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
| NCT ID | NCT04270045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Winston Manimtim |
| Condition | Infant, Premature, Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2020-02-06 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2020-02-06 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to use forced oscillometry technique (FOT) to measure pulmonary mechanics and function in in term infants and premature infants with bronchopulmonary dysplasia (BPD)
Eligibility Criteria
Inclusion Criteria: Preterm Cohort: * Premature infants with BPD who are in room air based on the (per NICHD definition) * Premature infants with BPD who are receiving low flow O2 support and able to maintain normal spO2 in Room air for brief period ( up to 3 minutes) Term Cohort without pulmonary disease * Infants \>36 weeks gestational age without pulmonary disease * Infants \< 4 weeks of age Outpatient Cohort: * Former preterm infants \< 32 weeks at birth * Those with BPD based on NIH 2001 definition * Seen prior to 2 years of age Exclusion Criteria: * Infants with BPD requiring invasive or non-invasive positive pressure ventilation * Infants with BPD who have associated genetic diagnosis or major congenital anomalies.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04270045 clinical trial?
This trial is open to participants of all sexes, studying Infant, Premature, Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04270045 currently recruiting?
Yes, NCT04270045 is actively recruiting participants. Contact the research team at wmmanimtim@cmh.edu for enrollment information.
Where is the NCT04270045 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT04270045 clinical trial?
NCT04270045 is sponsored by Winston Manimtim. The trial plans to enroll 80 participants.